Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06063538 · ClinicalTrials.gov registry record · Early Phase 1

Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone

A Early Phase 1 study of Atrial Fibrillation and Post-Op Complication, sponsored by University of Chicago.

Recruiting
Registry status
Early Phase 1
Development phase
63
Enrollment target
1
Study location

NCT06063538 is a Early Phase 1 study of Atrial Fibrillation and Post-Op Complication that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 63 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06063538, a Early Phase 1 study of Atrial Fibrillation and Post-Op Complication, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
Early Phase 1
Development phase
63 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the combination of CardiaMend, with the addition of amiodarone in the prevention of postoperative atrial fibrillation (POAF) in patients undergoing cardiac arterial bypass grafting (CABG) or valve surgery.

Conditions Studied

Atrial Fibrillation Post-Op Complication

Interventions

  • COMBINATION_PRODUCT CardiaMend in Combination with Amiodarone

Study Locations (1)

Illinois

  • The University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2024-02-15
Est. Completion 2027-06
Phase Early Phase 1

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06063538

The ClinicalTrials.gov registry entry for NCT06063538 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which CardiaMend in Combination with Amiodarone is the first listed.

NCT06063538 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06063538 about?

NCT06063538 is a clinical study titled "Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone". The purpose of this study is to evaluate the combination of CardiaMend, with the addition of amiodarone in the prevention of postoperative atrial fibrillation (POAF) in patients undergoing cardiac arterial bypass grafting (CABG) or valve surgery.

What is the current status of trial NCT06063538?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 63 participants. The study started on 2024-02-15. Estimated completion is 2027-06.

What conditions does trial NCT06063538 study?

This clinical trial studies the following conditions: Atrial Fibrillation, Post-Op Complication.

What interventions are being tested in trial NCT06063538?

The interventions under investigation include: CardiaMend in Combination with Amiodarone (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT06063538?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06063538 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Post-Op Complication

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.